This study aims to decipher the potential effects of nebivolol in prevention and/or regression
of renal artery dysfunction in diabetes associated with hypertension. Renal arteries were …

Objective Atenolol, a first-generation β-blocker, effectively reduces blood pressure, although
its use in metabolic syndrome remains controversial. Accordingly, this study evaluated the …

The aim was to evaluate the effects and mechanisms of nebivolol on renal damage in
Zucker diabetic fatty (ZDF) rats, in comparison with those of atenolol and captopril. Animals …

Background Although effective in reducing blood pressure, therapy with a first-generation β-
blocker is currently controversial in metabolic syndrome due to its negative impact on …

BACKGROUND: Many diabetics develop hypertension, and it is a major risk factor for
cardiovascular and microvascular complications. OBJECTIVE: To review a case study of a …

Nebivolol is a new selective beta 1-adrenoceptor antagonist with nitric oxide (NO)–releasing
properties. In the present study we have analyzed whether nebivolol affects the …

Background Endothelial cell (EC) dysfunction contributes to hypertension and mechanisms
of atherosclerosis. Agents that improve EC function may provide vascular protection …

Diabetes-induced vascular dysfunction has mainly been studied in males. However, the
mechanisms involved may not correspond to those in females. Here we analyzed the effects …

Background: Effective blood pressure (BP)-lowering therapy is regarded as the most
important intervention in diabetes mellitus. Nebivolol is commonly used for the treatment of …

Background Vascular endothelial dysfunction may predict future atherosclerosis. Hence, an
antihypertensive agent that reverses endothelial dysfunction and lowers blood pressure …